Dixon Technologies ka Target Gira, Canara Bank 'Add' par! HDFC Securities ke Stock Calls Check Karo

BROKERAGE-REPORTS
Whalesbook Logo
AuthorAarav Shah|Published at:
Dixon Technologies ka Target Gira, Canara Bank 'Add' par! HDFC Securities ke Stock Calls Check Karo
Overview

Arre bhaiyo, HDFC Securities ne apna Q4 review update kar diya hai aur kuch stocks par milti-julti rai di hai. Dixon Technologies ko 'Reduce' rating mili hai aur target bhi kam kar diya hai, jabki Canara Bank ko 'Add' rating par maintain rakha hai. Dr. Reddy's Laboratories ka bhi outlook thoda weak lag raha hai.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Dixon Technologies: Margins aur Demand ki Fikar

HDFC Securities ne Dixon Technologies ki rating ko 'Reduce' kar diya hai aur target price set kiya hai ₹10,560. Company ka revenue sirf 2% hi badha hai year-on-year, aur EBITDA bhi kam hua hai margin dabav (compression) aur mandi wali demand ki wajah se. Production Linked Incentive (PLI) schemes ka band hona aur handset market ki dheemi raftaar bhi iske outlook ko challenging bana rahi hai.

Canara Bank: Mixed Signal, Par 'Add' Rating?

Canara Bank ke liye loan growth acchi khasi 16% year-on-year dikh rahi hai, khas kar retail aur MSME segments mein. Lekin, earnings mein fluctuations the, treasury income kam thi aur bank ko non-core revenue streams par depend karna pad raha hai. HDFC Securities ne 'Add' rating ko ₹155 ke target ke saath maintain kiya hai, lekin bank ki deposit strength aur earnings mein ups and downs par thoda sawal uthaya hai.

Dr. Reddy's Laboratories: US Business Ka Pressure

Dr. Reddy's Laboratories ka EBITDA 42% gir gaya hai agar pichhle saal se compare karein. Iska main reason hai US business mein sales ka kafi kam hona aur margin ka tight ho jaana. Company ki growth ab Semaglutide launches aur unke biosimilars pipeline par depend karegi. HDFC Securities ne 'Reduce' rating ko reiterate kiya hai aur target price ₹1,260 rakha hai.

Is report mein Berger Paints, Syrma SGS Technology, aur Stylam jaise stocks par bhi calls hain, jo investors ko alag alag quarterly results par naye perspectives de rahe hain.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.